Search

Your search keyword '"Golan E"' showing total 192 results
Start Over Author "Golan E" Publication Year Range Last 50 years
192 results on '"Golan E"'

1. Magnetic-film atom chip with 10 $\mu$m period lattices of microtraps for quantum information science with Rydberg atoms

Author

Leung, V. Y. F., Pijn, D. R. M., Schlatter, H., Torralbo-Campo, L., La Rooij, A., Mulder, G. B., Naber, J., Soudijn, M. L., Tauschinsky, A., Abarbanel, C., Hadad, B., Golan, E., Folman, R., and Spreeuw, R. J. C.

Subjects
Physics - Atomic Physics, Quantum Physics
Abstract

We describe the fabrication and construction of a setup for creating lattices of magnetic microtraps for ultracold atoms on an atom chip. The lattice is defined by lithographic patterning of a permanent magnetic film. Patterned magnetic-film atom chips enable a large variety of trapping geometries over a wide range of length scales. We demonstrate an atom chip with a lattice constant of 10 $\mu$m, suitable for experiments in quantum information science employing the interaction between atoms in highly-excited Rydberg energy levels. The active trapping region contains lattice regions with square and hexagonal symmetry, with the two regions joined at an interface. A structure of macroscopic wires, cut out of a silver foil, was mounted under the atom chip in order to load ultracold $^{87}$Rb atoms into the microtraps. We demonstrate loading of atoms into the square and hexagonal lattice sections simultaneously and show resolved imaging of individual lattice sites. Magnetic-film lattices on atom chips provide a versatile platform for experiments with ultracold atoms, in particular for quantum information science and quantum simulation., Comment: 7 pages, 7 figures

Published
2013
Full Text
View/download PDF

5. Effect of Probiotics on Incident Ventilator-Associated Pneumonia in Critically Ill Patients A Randomized Clinical Trial

Author

Johnstone, J, Meade, M, Lauzier, F, Marshall, J, Duan, E, Dionne, J, Arabi, YM, Heels-Ansdell, D, Thabane, L, Lamarche, D, Surette, M, Zytaruk, N, Mehta, S, Dodek, P, McIntyre, L, English, S, Rochwerg, B, Karachi, T, Henderson, W, Wood, G, Ovakim, D, Herridge, M, Granton, J, Wilcox, ME, Goffi, A, Stelfox, HT, Niven, D, Muscedere, J, Lamontagne, F, D'Aragon, F, St-Arnaud, C, Ball, I, Nagpal, D, Girard, M, Aslanian, P, Charbonney, E, Williamson, D, Sligl, W, Friedrich, J, Adhikari, NK, Marquis, F, Archambault, P, Khwaja, K, Kristof, A, Kutsogiannis, J, Zarychanski, R, Paunovic, B, Reeve, B, Lellouche, F, Hosek, P, Tsang, J, Binnie, A, Trop, S, Loubani, O, Hall, R, Cirone, R, Reynolds, S, Lysecki, P, Golan, E, Cartin-Ceba, R, Taylor, R, Cook, D, Mancebo J., and Gramish, Jawaher A.

Abstract

Question Does the probiotic Lactobacillus rhamnosus GG prevent ventilator-associated pneumonia (VAP) among critically ill patients? Findings In this randomized trial involving 2650 patients, no significant difference in VAP incidence was found among patients treated with probiotics compared with placebo (21.9% vs 21.3%, respectively; hazard ratio 1.03; 95% CI 0.87-1.22). Meaning These findings do not support the use of Lactobacillus rhamnosus GG for prevention of ventilator-associated pneumonia in critically ill patients requiring mechanical ventilation. Importance Growing interest in microbial dysbiosis during critical illness has raised questions about the therapeutic potential of microbiome modification with probiotics. Prior randomized trials in this population suggest that probiotics reduce infection, particularly ventilator-associated pneumonia (VAP), although probiotic-associated infections have also been reported. Objective To evaluate the effect of Lactobacillus rhamnosus GG on preventing VAP, additional infections, and other clinically important outcomes in the intensive care unit (ICU). Design, Setting, and Participants Randomized placebo-controlled trial in 44 ICUs in Canada, the United States, and Saudi Arabia enrolling adults predicted to require mechanical ventilation for at least 72 hours. A total of 2653 patients were enrolled from October 2013 to March 2019 (final follow-up, October 2020). Interventions Enteral L rhamnosus GG (1 x 10(10) colony-forming units) (n = 1321) or placebo (n = 1332) twice daily in the ICU. Main Outcomes and Measures The primary outcome was VAP determined by duplicate blinded central adjudication. Secondary outcomes were other ICU-acquired infections including Clostridioides difficile infection, diarrhea, antimicrobial use, ICU and hospital length of stay, and mortality. Results Among 2653 randomized patients (mean age, 59.8 years [SD], 16.5 years), 2650 (99.9%) completed the trial (mean age, 59.8 years [SD], 16.5 years; 1063 women [40.1%.] with a mean Acute Physiology and Chronic Health Evaluation II score of 22.0 (SD, 7.8) and received the study product for a median of 9 days (IQR, 5-15 days). VAP developed among 289 of 1318 patients (21.9%) receiving probiotics vs 284 of 1332 controls (21.3%; hazard ratio [HR], 1.03 (95% CI, 0.87-1.22; P = .73, absolute difference, 0.6%, 95% CI, -2.5% to 3.7%). None of the 20 prespecified secondary outcomes, including other ICU-acquired infections, diarrhea, antimicrobial use, mortality, or length of stay showed a significant difference. Fifteen patients (1.1%) receiving probiotics vs 1 (0.1%) in the control group experienced the adverse event of L rhamnosus in a sterile site or the sole or predominant organism in a nonsterile site (odds ratio, 14.02; 95% CI, 1.79-109.58; P < .001). Conclusions and Relevance Among critically ill patients requiring mechanical ventilation, administration of the probiotic L rhamnosus GG compared with placebo, resulted in no significant difference in the development of ventilator-associated pneumonia. These findings do not support the use of L rhamnosus GG in critically ill patients. This clinical trial assessed whether Lactobacillus rhamnosus GG compared with placebo reduces ventilator-associated pneumonia and other clinically important outcomes for a broad range of critically ill patients.

Published
2021

6. The ERA-EDTA Registry Annual Report 2018: a summary

Author

Universidad de Sevilla. Departamento de Medicina, Borroni, Davide, Boenink, R, Stel, VS, de Pablos, CS, Tomovic, F, Golan, E, Muñoz Terol, José Manuel, Jager, KJ, Universidad de Sevilla. Departamento de Medicina, Borroni, Davide, Boenink, R, Stel, VS, de Pablos, CS, Tomovic, F, Golan, E, Muñoz Terol, José Manuel, and Jager, KJ

Abstract

Background The European Renal Association – European Dialysis and Transplant Association (ERA-EDTA) Registry collects data on kidney replacement therapy (KRT) via national and regional renal registries in Europe and countries bordering the Mediterranean Sea. This article summarizes the 2018 ERA-EDTA Registry Annual Report, and describes the epidemiology of KRT for kidney failure in 34 countries. Methods Individual patient data on patients undergoing KRT in 2018 were provided by 34 national or regional renal registries and aggregated data by 17 registries. The incidence and prevalence of KRT, the kidney transplantation activity and the survival probabilities of these patients were calculated. Results In 2018, the ERA-EDTA Registry covered a general population of 636 million people. Overall, the incidence of KRT for kidney failure was 129 per million population (p.m.p.), 62% of patients were men, 51% were ≥65 years of age and 20% had diabetes mellitus as cause of kidney failure. Treatment modality at the onset of KRT was haemodialysis (HD) for 84%, peritoneal dialysis (PD) for 11% and pre-emptive kidney transplantation for 5% of patients. On 31 December 2018, the prevalence of KRT was 897 p.m.p., with 57% of patients on HD, 5% on PD and 38% living with a kidney transplant. The transplant rate in 2018 was 35 p.m.p.: 68% received a kidney from a deceased donor, 30% from a living donor and for 2% the donor source was unknown. For patients commencing dialysis during 2009–13, the unadjusted 5-year survival probability was 42.6%. For patients receiving a kidney transplant within this period, the unadjusted 5-year survival probability was 86.6% for recipients of deceased donor grafts and 93.9% for recipients of living donor grafts.

Published
2021

7. Standards for Studies of Neurological Prognostication in Comatose Survivors of Cardiac Arrest: A Scientific Statement from the American Heart Association

Author

Geocadin, R. G., Callaway, C. W., Fink, E. L., Golan, E., Greer, D. M., Ko, N. U., Lang, E., Licht, D. J., Marino, B. S., Mcnair, N. D., Peberdy, M. A., Perman, S. M., Sims, D. B., Soar, J., Sandroni, Claudio, Sandroni C. (ORCID:0000-0002-8878-2611), Geocadin, R. G., Callaway, C. W., Fink, E. L., Golan, E., Greer, D. M., Ko, N. U., Lang, E., Licht, D. J., Marino, B. S., Mcnair, N. D., Peberdy, M. A., Perman, S. M., Sims, D. B., Soar, J., Sandroni, Claudio, and Sandroni C. (ORCID:0000-0002-8878-2611)

Abstract

Significant improvements have been achieved in cardiac arrest resuscitation and postarrest resuscitation care, but mortality remains high. Most of the poor outcomes and deaths of cardiac arrest survivors have been attributed to widespread brain injury. This brain injury, commonly manifested as a comatose state, is a marker of poor outcome and a major basis for unfavorable neurological prognostication. Accurate prognostication is important to avoid pursuing futile treatments when poor outcome is inevitable but also to avoid an inappropriate withdrawal of life-sustaining treatment in patients who may otherwise have a chance of achieving meaningful neurological recovery. Inaccurate neurological prognostication leading to withdrawal of life-sustaining treatment and deaths may significantly bias clinical studies, leading to failure in detecting the true study outcomes. The American Heart Association Emergency Cardiovascular Care Science Subcommittee organized a writing group composed of adult and pediatric experts from neurology, cardiology, emergency medicine, intensive care medicine, and nursing to review existing neurological prognostication studies, the practice of neurological prognostication, and withdrawal of life-sustaining treatment. The writing group determined that the overall quality of existing neurological prognostication studies is low. As a consequence, the degree of confidence in the predictors and the subsequent outcomes is also low. Therefore, the writing group suggests that neurological prognostication parameters need to be approached as index tests based on relevant neurological functions that are directly related to the functional outcome and contribute to the quality of life of cardiac arrest survivors. Suggestions to improve the quality of adult and pediatric neurological prognostication studies are provided.

Published
2019

10. The pyramidalis-anterior pubic ligament-adductor longus complex (PLAC) and its role with adductor injuries: a new anatomical concept.

Author

Schilders, E, Bharam, S, Golan, E, Dimitrakopoulou, A, Mitchell, A, Spaepen, M, Beggs, CB, Cooke, CB, Holmich, P, Schilders, E, Bharam, S, Golan, E, Dimitrakopoulou, A, Mitchell, A, Spaepen, M, Beggs, CB, Cooke, CB, and Holmich, P

Abstract

PURPOSE: Adductor longus injuries are complex. The conflict between views in the recent literature and various nineteenth-century anatomy books regarding symphyseal and perisymphyseal anatomy can lead to difficulties in MRI interpretation and treatment decisions. The aim of the study is to systematically investigate the pyramidalis muscle and its anatomical connections with adductor longus and rectus abdominis, to elucidate injury patterns occurring with adductor avulsions. METHODS: A layered dissection of the soft tissues of the anterior symphyseal area was performed on seven fresh-frozen male cadavers. The dimensions of the pyramidalis muscle were measured and anatomical connections with adductor longus, rectus abdominis and aponeuroses examined. RESULTS: The pyramidalis is the only abdominal muscle anterior to the pubic bone and was found bilaterally in all specimens. It arises from the pubic crest and anterior pubic ligament and attaches to the linea alba on the medial border. The proximal adductor longus attaches to the pubic crest and anterior pubic ligament. The anterior pubic ligament is also a fascial anchor point connecting the lower anterior abdominal aponeurosis and fascia lata. The rectus abdominis, however, is not attached to the adductor longus; its lateral tendon attaches to the cranial border of the pubis; and its slender internal tendon attaches inferiorly to the symphysis with fascia lata and gracilis. CONCLUSION: The study demonstrates a strong direct connection between the pyramidalis muscle and adductor longus tendon via the anterior pubic ligament, and it introduces the new anatomical concept of the pyramidalis-anterior pubic ligament-adductor longus complex (PLAC). Knowledge of these anatomical relationships should be employed to aid in image interpretation and treatment planning with proximal adductor avulsions. In particular, MRI imaging should be employed for all proximal adductor longus avulsions to assess the integrity of the PLAC.

Published
2017

11. Magnetic-film atom chip setup with 10 µm period lattices of magnetic microtraps for quantum information science with Rydberg atoms

Author

Leung, Y.F.V., Pijn, D.R.M., Schlatter, H., Torallo-Campo, L., La Rooij, A., Mulder, G.B., Naber, J., Soudijn, M.L., Tauschinsky, A., Abarbanel, C., Hadad, B., Golan, E., Folman, R., Spreeuw, R.J.C., Complex Photonic Systems, and Faculty of Science and Technology

Subjects
Condensed Matter::Quantum Gases, METIS-301200, Physics::Atomic and Molecular Clusters, Physics::Atomic Physics, IR-90105
Abstract

We describe the fabrication and construction of a setup for creating lattices of magnetic microtraps for ultracold atoms on an atom chip. The lattice is defined by lithographic patterning of a permanent magnetic film. Patterned magnetic-film atom chips enable a large variety of trapping geometries over a wide range of length scales. We demonstrate an atom chip with a lattice constant of 10 μm, suitable for experiments in quantum information science employing the interaction between atoms in highly excited Rydberg energy levels. The active trapping region contains lattice regions with square and hexagonal symmetry, with the two regions joined at an interface. A structure of macroscopic wires, cutout of a silver foil, was mounted under the atom chip in order to load ultracold 87Rb atoms into the microtraps. We demonstrate loading of atoms into the square and hexagonal lattice sections simultaneously and show resolved imaging of individual lattice sites. Magnetic-film lattices on atom chips provide a versatile platform for experiments with ultracold atoms, in particular for quantum information science and quantum simulation.

Published
2014

12. Renal replacement therapy in Europe: a summary of the 2012 ERA-EDTA Registry Annual Report

Author

Pippias, M., Stel, V.S., Diez, J.M. Abad, Afentakis, N., Herrero-Calvo, J.A., Arias, M., Tomilina, N., Caamano, E. Bouzas, Buturovic-Ponikvar, J., Cala, S., Caskey, F.J., Nuez, P. Castro de la, Cernevskis, H., Collart, F., Torre, R. Alonso de la, Mde, L. Hoya, Meester, J. de, Diaz, J.M., Djukanovic, L., Alamar, M. Ferrer, Finne, P., Garneata, L., Golan, E., Fernandez, R., Avila, G. Gutierrez, Heaf, J., Hoitsma, A.J., Kantaria, N., Kolesnyk, M., Kramar, R., Kramer, A., Lassalle, M., Leivestad, T., Lopot, F., Macario, F., Magaz, A., Martin-Escobar, E., Metcalfe, W., Noordzij, M., Palsson, R., Pechter, U., Prutz, K.G., Ratkovic, M., Resic, H., Rutkowski, B., Pablos, C. Santiuste de, Spustova, V., Suleymanlar, G., Stralen, K. Van, Thereska, N., Wanner, C., Jager, K.J., Pippias, M., Stel, V.S., Diez, J.M. Abad, Afentakis, N., Herrero-Calvo, J.A., Arias, M., Tomilina, N., Caamano, E. Bouzas, Buturovic-Ponikvar, J., Cala, S., Caskey, F.J., Nuez, P. Castro de la, Cernevskis, H., Collart, F., Torre, R. Alonso de la, Mde, L. Hoya, Meester, J. de, Diaz, J.M., Djukanovic, L., Alamar, M. Ferrer, Finne, P., Garneata, L., Golan, E., Fernandez, R., Avila, G. Gutierrez, Heaf, J., Hoitsma, A.J., Kantaria, N., Kolesnyk, M., Kramar, R., Kramer, A., Lassalle, M., Leivestad, T., Lopot, F., Macario, F., Magaz, A., Martin-Escobar, E., Metcalfe, W., Noordzij, M., Palsson, R., Pechter, U., Prutz, K.G., Ratkovic, M., Resic, H., Rutkowski, B., Pablos, C. Santiuste de, Spustova, V., Suleymanlar, G., Stralen, K. Van, Thereska, N., Wanner, C., and Jager, K.J.

Abstract

Contains fulltext : 155733.pdf (Publisher’s version ) (Open Access), BACKGROUND: This article summarizes the 2012 European Renal Association-European Dialysis and Transplant Association Registry Annual Report (available at www.era-edta-reg.org) with a specific focus on older patients (defined as >/=65 years). METHODS: Data provided by 45 national or regional renal registries in 30 countries in Europe and bordering the Mediterranean Sea were used. Individual patient level data were received from 31 renal registries, whereas 14 renal registries contributed data in an aggregated form. The incidence, prevalence and survival probabilities of patients with end-stage renal disease (ESRD) receiving renal replacement therapy (RRT) and renal transplantation rates for 2012 are presented. RESULTS: In 2012, the overall unadjusted incidence rate of patients with ESRD receiving RRT was 109.6 per million population (pmp) (n = 69 035), ranging from 219.9 pmp in Portugal to 24.2 pmp in Montenegro. The proportion of incident patients >/=75 years varied from 15 to 44% between countries. The overall unadjusted prevalence on 31 December 2012 was 716.7 pmp (n = 451 270), ranging from 1670.2 pmp in Portugal to 146.7 pmp in the Ukraine. The proportion of prevalent patients >/=75 years varied from 11 to 32% between countries. The overall renal transplantation rate in 2012 was 28.3 pmp (n = 15 673), with the highest rate seen in the Spanish region of Catalonia. The proportion of patients >/=65 years receiving a transplant ranged from 0 to 35%. Five-year adjusted survival for all RRT patients was 59.7% (95% confidence interval, CI: 59.3-60.0) which fell to 39.3% (95% CI: 38.7-39.9) in patients 65-74 years and 21.3% (95% CI: 20.8-21.9) in patients >/=75 years.

Published
2015

13. Magnetic-film atom chip with 10 μm period lattices of microtraps for quantum information science with Rydberg atoms

Author

Leung, V. Y. F., primary, Pijn, D. R. M., additional, Schlatter, H., additional, Torralbo-Campo, L., additional, La Rooij, A. L., additional, Mulder, G. B., additional, Naber, J., additional, Soudijn, M. L., additional, Tauschinsky, A., additional, Abarbanel, C., additional, Hadad, B., additional, Golan, E., additional, Folman, R., additional, and Spreeuw, R. J. C., additional

Published
2014
Full Text
View/download PDF

14. Renal replacement therapy in Europe: a summary of the 2011 ERA-EDTA Registry Annual Report

Author

Noordzij, M., primary, Kramer, A., additional, Abad Diez, J. M., additional, Alonso de la Torre, R., additional, Arcos Fuster, E., additional, Bikbov, B. T., additional, Bonthuis, M., additional, Bouzas Caamano, E., additional,  ala, S., additional, Caskey, F. J., additional, Castro de la Nuez, P., additional, Cernevskis, H., additional, Collart, F., additional, Diaz Tejeiro, R., additional, Djukanovic, L., additional, Ferrer-Alamar, M., additional, Finne, P., additional, Garcia Bazaga, M. d. l. A., additional, Garneata, L., additional, Golan, E., additional, Gonzalez Fernandez, R., additional, Heaf, J. G., additional, Hoitsma, A., additional, Ioannidis, G. A., additional, Kolesnyk, M., additional, Kramar, R., additional, Lasalle, M., additional, Leivestad, T., additional, Lopot, F., additional, van de Luijtgaarden, M. W. M., additional, Macario, F., additional, Magaz, A., additional, Martin Escobar, E., additional, de Meester, J., additional, Metcalfe, W., additional, Ots-Rosenberg, M., additional, Palsson, R., additional, Pinera, C., additional, Pippias, M., additional, Prutz, K. G., additional, Ratkovic, M., additional, Resi , H., additional, Rodriguez Hernandez, A., additional, Rutkowski, B., additional, Spustova, V., additional, Stel, V. S., additional, Stojceva-Taneva, O., additional, Suleymanlar, G., additional, Wanner, C., additional, and Jager, K. J., additional

Published
2014
Full Text
View/download PDF

16. Diabetes - experimental models

Author

Blanco-Gozalo, V., primary, Blazquez-Medela, A., additional, Garcia-Sanchez, O., additional, Quiros, Y., additional, Montero, M., additional, Martinez-Salgado, C., additional, Lopez-Hernandez, F., additional, Lopez-Novoa, J., additional, Yao, L., additional, Qing, Z., additional, Hua, X., additional, Min, F., additional, Fei, M., additional, Ning, W., additional, Cantaluppi, V., additional, Figliolini, F., additional, Delena, M., additional, Beltramo, S., additional, Medica, D., additional, Tetta, C., additional, Segoloni, G., additional, Biancone, L., additional, Camussi, G., additional, Cunha, J. S., additional, Ferreira, V. M., additional, Naves, M. A., additional, Boim, M. A., additional, Zitman-Gal, T., additional, Golan, E., additional, Green, J., additional, Pasmanik-Chor, M., additional, Bernheim, J., additional, Benchetrit, S., additional, Riera, M., additional, Clotet, S., additional, Pascual, J., additional, Soler, M., additional, Nakai, K., additional, Fujii, H., additional, Kono, K., additional, Goto, S., additional, Hirata, M., additional, Shinohara, M., additional, Fukagawa, M., additional, Nishi, S., additional, Fan, Q., additional, Du, S., additional, Jiang, Y., additional, Wang, L., additional, Fang, L., additional, Radovits, T., additional, Mozes, M. M., additional, Rosivall, L., additional, Kokeny, G., additional, Aoki, R., additional, Tateoka, R., additional, Sekine, F., additional, Kikuchi, K., additional, Yamashita, Y., additional, Itoh, Y., additional, Cappuccino, L., additional, Garibotto, G., additional, D'Amato, E., additional, Villaggio, B., additional, Gianiorio, F., additional, Mij, M., additional, Viazzi, F., additional, Salvidio, G., additional, Verzola, D., additional, Piwkowska, A., additional, Rogacka, D., additional, Audzeyenka, I., additional, Kasztan, M., additional, Angielski, S., additional, Jankowski, M., additional, Gaber, E. W., additional, El-Attar, H. A., additional, Liu, J., additional, Zhang, W., additional, He, Y., additional, Macsai, E., additional, Takats, Z., additional, Derzbach, L., additional, Korner, A., additional, Vasarhelyi, B., additional, Huang, M. S., additional, Bo, H., additional, Liu, F., additional, Fu, P., additional, Tsotakos, N. E., additional, Tsilibary, E. C., additional, Drossopoulou, G. I., additional, Thawho, N., additional, Farid, N., additional, Peleg, A., additional, Levy, A., additional, Nakhoul, N., additional, Lenghel, A. R., additional, Borza, G., additional, Catoi, C., additional, Bondor, C. I., additional, Muresan, A., additional, Kacso, I. M., additional, Song, J.-S., additional, Song, J.-H., additional, Ahn, S.-H., additional, Choi, B. S., additional, Hong, Y. a., additional, Kim, M. Y., additional, Lim, J. H., additional, Yang, K.-S., additional, Chung, S., additional, Shin, S. J., additional, Kim, H. W., additional, Chang, Y. S., additional, Kim, Y. S., additional, Park, C. W., additional, Takayanagi, K., additional, Hasegawa, H., additional, Shimizu, T., additional, Ikari, A., additional, Noiri, C., additional, Iwashita, T., additional, Tayama, Y., additional, Asakura, J., additional, Anzai, N., additional, Kanozawa, K., additional, Kato, H., additional, Mitarai, T., additional, Huang, M., additional, Ashour, R. H., additional, Fouda, A. E.-M. M., additional, Saad, M. A., additional, El-Banna, F. M., additional, Moustafa, F. A., additional, Fouda, M. I., additional, Sanchez-Nino, M. D., additional, Sanz, A. B., additional, Poveda, J., additional, Saleem, M., additional, Mathieson, P., additional, Ruiz-Ortega, M., additional, Selgas, R., additional, Egido, J., additional, Ortiz, A., additional, Soler, M. J., additional, Rebull, M., additional, Marquez, E., additional, Okazaki, S., additional, Kogure, Y., additional, Sano, T., additional, Hatano, M., additional, Kreft, E., additional, Kowalski, R., additional, Szczepansk-Konkel, M., additional, Liu, X., additional, Yang, G., additional, Osman, N. A., additional, NasrAllah, M. M., additional, Kamal, M. M., additional, Ahmed, A. I., additional, Fekih-Mrissa, N., additional, Mrad, M., additional, Baffoun, A., additional, Sayeh, A., additional, Hmida, J., additional, Gritli, N., additional, Galchinskaya, V., additional, Topchii, I., additional, Semenovykh, P., additional, Yefimova, N., additional, Zheng, D., additional, Hu, D., additional, Li, X., additional, Peng, A. I., additional, Olea-Herrero, N., additional, Arenas, M., additional, Munoz-Moreno, C., additional, Moreno-Gomez-Toledano, R., additional, Gonzalez-Santander, M., additional, Arribas, I., additional, and Bosch, R., additional

Published
2013
Full Text
View/download PDF

18. Mineral and bone disease - CKD 5D

Author

Hecking, M., primary, Kainz, A., additional, Bielesz, B., additional, Plischke, M., additional, Beilhack, G., additional, Hoerl, W. H., additional, Sunder-Plassmann, G., additional, Bieglmayer, C., additional, Benchetrit, S., additional, Green, J., additional, Bernheim, J., additional, Golan, E., additional, Oyake, N., additional, Suzuki, K., additional, Itoh, S., additional, Tanabe, K., additional, Fujimori, A., additional, Okada, S., additional, Yamamoto, K., additional, Sakai, M., additional, Kamiura, N., additional, Solenne, P., additional, Guebre-Egziabher, F., additional, Bacchetta, J., additional, Drai, J., additional, Richard, M., additional, Chapurlat, R., additional, Fouque, D., additional, Nowak, Z., additional, Grzegorz, K., additional, Maria, K., additional, Zofia, W., additional, Zamboch, K., additional, Zahalkova, J., additional, Kosatikova, Z., additional, Skypalova, P., additional, Skarda, J., additional, Cunha, J., additional, Boim, M., additional, Ferreira, V., additional, Naves, M., additional, Kikuchi, H., additional, Shimada, H., additional, Takimoto, Y., additional, Karasawa, R., additional, Shimotori, M., additional, Ikarashi, K., additional, Saito, N., additional, Miyazaki, S., additional, Sakai, S., additional, Suzuki, M., additional, Ogata, H., additional, Takeshima, A., additional, Yamamoto, M., additional, Asakura, K., additional, Kato, T., additional, Shishido, K., additional, Koiwa, F., additional, Mizobuchi, M., additional, Kinugasa, E., additional, Akizawa, T., additional, Londrino, F., additional, Corbani, V., additional, Ardini, M., additional, Falqui, V., additional, Zattera, T., additional, Rombola', G., additional, Takeshige, Y., additional, Matsuzaka, K., additional, Ciceri, P., additional, Volpi, E., additional, Brenna, I., additional, Elli, F., additional, Borghi, E., additional, Brancaccio, D., additional, Cozzolino, M., additional, Farrand, K., additional, Copley, J. B., additional, Heise, J., additional, Fridman, M., additional, Keith, M., additional, Silverberg, A., additional, Wilson, R., additional, Poole, L., additional, Jean, G., additional, Bresson, E., additional, Chazot, C., additional, Maduell, F., additional, Arias, M., additional, Sentis, A., additional, Rodriguez, N., additional, Jimenez, S., additional, Alemany, B., additional, Perez, N., additional, Vera, M., additional, Fontsere, N., additional, Carrera, M., additional, Cases, A., additional, Sonikian, M., additional, Miha, T., additional, Skarakis, I., additional, Karatzas, I., additional, Karaitianou, A., additional, Tomanoski, V., additional, Petkovic, D., additional, Curic, I., additional, Hrvacevic, R., additional, Kaperonis, N., additional, Kourvelou, C., additional, Sgantzos, A., additional, Nastou, D., additional, Ntatsis, G., additional, Ziakka, S., additional, Karakasis, F., additional, Nikolopoulos, V., additional, Zoubaniotou, D., additional, Koutsovasili, A., additional, Zagorianakos, A., additional, Kolovos, V., additional, Papagalanis, N., additional, Forni, V., additional, Pruijm, M., additional, Tousset, E., additional, Zweiacker, C., additional, Menetrey, I., additional, Berwert, L., additional, Bullani, R., additional, Cherpillod, A., additional, Gabutti, L., additional, Gauthier, T., additional, Halabi, G., additional, Mathieu, C., additional, Meier, P., additional, Phan, O., additional, Pianca, S., additional, Schoenholzer, C., additional, Teta, D., additional, Von Albertini, B., additional, Vrijens, B., additional, Burnier, M., additional, Kurita, N., additional, Fukagawa, M., additional, Onishi, Y., additional, Yamaguchi, T., additional, Hasegawa, T., additional, Fukuma, S., additional, Kurokawa, K., additional, Fukuhara, S., additional, Urena, P., additional, Bridges, I., additional, Christiano, C., additional, Cournoyer, S., additional, Cooper, K., additional, Farouk, M., additional, Kopyt, N., additional, Rodriguez, M., additional, Zehnder, D., additional, Covic, A., additional, Tominaga, Y., additional, Hiramitsu, T., additional, Yamamoto, T., additional, Nanmoku, K., additional, Matsuda, Y., additional, Tsuzuki, T., additional, Lang, C.-L., additional, Lu, K.-C., additional, Wang, M.-H., additional, Liu, S.-Y., additional, Huang, J.-W., additional, Chiang, C.-K., additional, Hung, K.-Y., additional, Bantis, C., additional, Kouri, N.-M., additional, Tsandekidou, E., additional, Frangidis, S., additional, Tsiandoulas, A., additional, Liakou, E., additional, Bamichas, G., additional, Stangou, M., additional, Papagianni, A., additional, Efstratiadis, G., additional, Natse, T., additional, Memmos, D., additional, Messa, P., additional, Cannella, G., additional, Mazzaferro, S., additional, Yu, X., additional, Bieber, B., additional, Guidinger, M., additional, Yang, X., additional, Tentori, F., additional, Pisoni, R., additional, Qian, J., additional, Chen, N., additional, Yan, Y., additional, Wang, M., additional, Zuo, L., additional, Wang, H., additional, Albert, J., additional, Ramirez, S., additional, Caccetta, F., additional, Caroppo, M., additional, Musio, F., additional, Mudoni, A., additional, Accogli, A., additional, Zacheo, M. D., additional, Nuzzo, V., additional, Selim, G., additional, Stojceva-Taneva, O., additional, Tozija, L., additional, Gelev, S., additional, Pusevski, V., additional, Dzekova-Vidimliski, P., additional, Rambabova-Busletic, I., additional, Sikole, A., additional, Esposito, P., additional, Coppo, R., additional, Malberti, F., additional, Dal Canton, A., additional, Moriwaki, K., additional, Komaba, H., additional, Kakuta, T., additional, Cernaro, V., additional, Lupica, R., additional, Donato, V., additional, Lacquaniti, A., additional, Fazio, M. R., additional, Lucisano, S., additional, Buemi, M., additional, Okuno, S., additional, Ishimura, E., additional, Tsuboniwa, N., additional, Norimine, K., additional, Yamakawa, K., additional, Yamakawa, T., additional, Shoji, S., additional, Mori, K., additional, Nishizawa, Y., additional, Inaba, M., additional, Dahaba, M., additional, Seck, S., additional, Cisse, M., additional, Jotoku, Y., additional, Sato, Y., additional, Dimkovic, N., additional, Asicioglu, E., additional, Kahveci, A., additional, Arikan, H., additional, Koc, M., additional, Tuglular, S., additional, Ozener, C., additional, Kido, R., additional, Yamaguch, T., additional, Krasniak, A., additional, Drozdz, M., additional, Chmiel, G., additional, Podolec, P., additional, Pasowicz, M., additional, Kowalczyk-Michalek, M., additional, Sulowicz, W., additional, Perez-Suarez, G., additional, Baamonde, E., additional, Bosch, E., additional, Ramirez, J. I., additional, El Hayek, B., additional, Lago, M. D. M., additional, Garcia, C., additional, Checa, M. D., additional, Hiramatsu, R., additional, Ubara, Y., additional, Salas, K., additional, Vicent, E. S., additional, Gonzalez Oliva, J. C., additional, Fulquet, M., additional, Duarte, V., additional, Pou, M., additional, Saurina, A., additional, Macias, J., additional, Ramirez de Arellano, M., additional, Matias, P., additional, Jorge, C., additional, Mendes, M., additional, Amaral, T., additional, Ferreira, C., additional, Aires, I., additional, Gil, C., additional, Ferreira, A., additional, Arcal, C., additional, Campistol, J. M., additional, Seferi, S., additional, Rroji, M., additional, Likaj, E., additional, Petrela, E., additional, Barbullushi, M., additional, Zeneli, N., additional, Mumajesi, S., additional, Thereska, N., additional, Vulpio, C., additional, Bossola, M., additional, Stigliano, E., additional, Fadda, G., additional, Gueiros, A. P. S., additional, Borba Junior, J. O., additional, Lordsllen, A. B. d. M. D. S., additional, Gueiros, J. E. d. B., additional, Itami, N., additional, Tuneyama, K., additional, Uemura, S., additional, Hamada, H., additional, Takada, J., additional, Takahashi, K., additional, Adamidis, K., additional, Apostolou, T., additional, Pleros, C., additional, Oikonomaki, T., additional, Kyratzi, E., additional, Exarchos, D., additional, Metaxatos, G., additional, Dracopoulos, S., additional, Nikolopoulou, N., additional, Delanaye, P., additional, Dubois, B., additional, Krzesinski, J.-M., additional, Cavalier, E., additional, De la Fuente, V., additional, Gil, M. T., additional, Gutierrez, P., additional, Delgado, P., additional, Ribero, J., additional, Arenas, L., additional, Sezer, S., additional, Tutal, E., additional, Bal, Z., additional, Erkmen Uyar, M., additional, Ozdemir Acar, F. N., additional, Azevedo de Oliveira, R., additional, Carvalho Barreto, F., additional, Dos Reis, L., additional, Cunha Ferreira, J., additional, Maria Leme Britto, Z., additional, Maria Moyses, R., additional, Jorgetti, V., additional, Ozelsancak, R., additional, Gurlek Demirci, B., additional, Torun, D., additional, Veljancic, L., additional, Radojevic, M., additional, Paunic, Z., additional, Vavic, N., additional, Obrencevic, K., additional, Kovacevic, Z., additional, and Pejovic, J., additional

Published
2012
Full Text
View/download PDF

19. Diabetes - Experimental

Author

Kang, K. P., primary, Lee, J. E., additional, Lee, A. S., additional, Jung, Y. J., additional, Lee, S., additional, Park, S. K., additional, Kim, W., additional, Pokrywczynska, M., additional, Jundzill, A., additional, Krzyzanowska, S., additional, Flisinski, M., additional, Brymora, A., additional, Bodnar, M., additional, Deptula, A., additional, Marszalek, A., additional, Manitius, J., additional, Drewa, T., additional, Kloskowski, T., additional, Grosjean, F., additional, Esposito, V., additional, Torreggiani, M., additional, Esposito, C., additional, Zheng, F., additional, Vlassara, H., additional, Striker, G., additional, Michael, S., additional, Viswanathan, P., additional, Ganesh, R., additional, Kimachi, M., additional, Nishio, S., additional, Nakazawa, D., additional, Ishikawa, Y., additional, Toyoyama, T., additional, Satou, A., additional, Nakagaki, T., additional, Shibasaki, S., additional, Atumi, T., additional, Gattone, V., additional, Peterson, R., additional, Zimmerman, K., additional, Mega, C., additional, Reis, F., additional, Teixeira de Lemos, E., additional, Vala, H., additional, Fernandes, R., additional, Oliveira, J., additional, Teixeira, F., additional, Niculae, A., additional, Checherita, I.-A., additional, Ciocalteu, A., additional, Hamano, Y., additional, Udagawa, Y., additional, Ueda, Y., additional, Yokosuka, O., additional, Ogawa, M., additional, Satoh, M., additional, Kidokoro, K., additional, Nagasu, H., additional, Nishi, Y., additional, Ihoriya, C., additional, Kadoya, H., additional, Yada, T., additional, Channon, K. M., additional, Sasaki, T., additional, Kashihara, N., additional, Nyengaard, J. R., additional, Razga, Z., additional, Hartono, S., additional, Knudsen, B., additional, Grande, J., additional, Watanabe, M., additional, Ito, K., additional, Abe, Y., additional, Ogahara, S., additional, Nakashima, H., additional, Sato, T., additional, Saito, T., additional, Shin, Y. T., additional, Choi, D. E., additional, Na, K.-R., additional, Chang, Y. K., additional, Kim, S. S., additional, Lee, K. W., additional, Mace, C., additional, Chugh, S., additional, Clement, L., additional, Tomochika, M., additional, Seiji, H., additional, Toshio, M., additional, Tetsuya, K., additional, Takao, K., additional, Jaen, J. C., additional, Sullivan, T. J., additional, Miao, Z., additional, Zhao, N., additional, Berahovich, R., additional, Krasinski, A., additional, Powers, J. P., additional, Ertl, L., additional, Schall, T. J., additional, Han, S. Y., additional, Sun, H.-K., additional, Han, K. H., additional, Kim, H.-S., additional, Ahn, S.-H., additional, Kokeny, G., additional, Gasparics, A., additional, Fang, L., additional, Rosivall, L., additional, Sebe, A., additional, Banki, N. F., additional, Fekete, A., additional, Wagner, L., additional, Ver, A., additional, Degrell, P., additional, Prokai, A., additional, George, R., additional, Szabo, A., additional, Baylis, C., additional, Vannay, A., additional, Tulassay, T., additional, Chollet, C., additional, Hus-Citharel, A., additional, Caron, N., additional, Bouby, N., additional, Silva, K., additional, Rampaso, R., additional, Luiz, R., additional, De Angelis, K., additional, Mostarda, C. T., additional, Abreu, N., additional, Irigoyen, M. C., additional, Schor, N., additional, Montemor, J., additional, Higa, E. M. S., additional, Nakayama, Y., additional, Fukami, K., additional, Obara, N., additional, Ando, R., additional, Kaida, Y., additional, Ueda, S., additional, Yamagishi, S.-I., additional, Okuda, S., additional, Qin, Q., additional, Wang, Z., additional, Niu, J., additional, Xu, W., additional, Qiao, Z., additional, Qi, W., additional, Gu, Y., additional, Zitman-Gal, T., additional, Golan, E., additional, Green, J., additional, Pasmanik-Chor, M., additional, Oron-Karni, V., additional, Bernheim, J., additional, Benchetrit, S., additional, Tang, R.-N., additional, Wu, M., additional, Gao, M., additional, Liu, H., additional, Zhang, X.-L., additional, and Liu, B. C., additional

Published
2012
Full Text
View/download PDF

21. Hypertension & hormones

Author

Jankowski, V., primary, Patzak, A., additional, Herget-Rosenthal, S., additional, Zidek, W., additional, Jankowski, J., additional, Jankowski, V., additional, Toelle, M., additional, van der Giet, M., additional, Bae, E. H., additional, Ma, S. K., additional, Lee, J., additional, Kim, S. W., additional, Jin, K., additional, Kim, H.-j., additional, Vaziri, N. D., additional, Osaki, K., additional, Suzuki, Y., additional, Sugaya, T., additional, Nishiyama, A., additional, Horikoshi, S., additional, Tomino, Y., additional, Matthesen, S. K., additional, Gjoerup, P. H., additional, Larsen, T., additional, Lauridsen, T. G., additional, Nykjaer, K. M., additional, Vase, H., additional, Pedersen, E. B., additional, Kim, Y. W., additional, Fujimori, A., additional, Yuyama, H., additional, Takakura, K., additional, Tahara, A., additional, Koakutsu, A., additional, Sanagi, M., additional, Sudoh, K., additional, Terada, Y., additional, Mizukami, K., additional, Miura, M., additional, Yokoyama, K., additional, Amano, Y., additional, Furukawa, T., additional, Tomura, Y., additional, Uchida, W., additional, Walkowska, A., additional, Kompanowska-Jezierska, E., additional, Sadowki, J., additional, Ozdemir, Z. N., additional, Sener, G., additional, Ozgur, S., additional, Koc, M., additional, Suleymanoglu, S., additional, Yegen, B., additional, Efrati, S., additional, Berman, S., additional, Abu-Hamad, R., additional, Siman-Tov, Y., additional, Weissgarten, J., additional, Hermida, R. C., additional, Ayala, D. E., additional, Mojon, A., additional, Chayan, L., additional, Dominguez, M. J., additional, Fontao, M. J., additional, Alonso, I., additional, Fernandez, J. R., additional, Zanoli, L., additional, Alivon, M., additional, Estrugo, N., additional, Ketthab, H., additional, Pruny, J.-F., additional, Yanes, S., additional, Bean, K., additional, Empana, J.-P., additional, Jouven, X., additional, Laude, R. D., additional, Laurent, S., additional, Boutouyrie, P., additional, Botticelli, I., additional, Quartagno, R., additional, Venturini, M., additional, Salvioni, M., additional, Lanzani, C., additional, Simonini, M., additional, Delli Carpini, S., additional, Zagato, L., additional, Manunta, P., additional, Blazquez-Medela, A. M., additional, Garcia-Ortiz, L., additional, Gomez-Marcos, M. A., additional, Recio-Rodriguez, J. I., additional, Martin-Hinojal, M., additional, Rodriguez-Martin, C., additional, Castano-Sanchez, C., additional, de Cabo-Laso, A., additional, Sanchez-Salgado, B., additional, Lopez-Novoa, J. M., additional, Martinez-Salgado, C., additional, Villevalde, S., additional, Tyukhmenev, E., additional, Klimenko, A., additional, Kobalava, Z., additional, Shin, S. j., additional, Oh, S. W., additional, Rhee, M.-y., additional, Schneider, M., additional, Janka, R., additional, Raff, U., additional, Ritt, M., additional, Ott, C., additional, Uder, M., additional, Schmieder, R., additional, Golan, E., additional, Bernheim, J., additional, Podjarny, E., additional, Ozturk, K., additional, Bulucu, F., additional, Gezer, M., additional, Kilic, S., additional, Steele, A., additional, Rene de Cotret, P., additional, Hubert, M., additional, Leclerc, J.-M., additional, Tran, L., additional, Rigal, R., additional, Christensen, F. H., additional, Bech, J. N., additional, Raju, B., additional, Nirmala, V. R., additional, Vijayalakshmi, J., additional, Kalaiselvi, M., additional, Rekha, K., additional, Paiva, C. E., additional, Leone Aguiar, A. F., additional, Coelho, E. B., additional, Irzyniec, T., additional, Jez, W., additional, Paterno, J. C., additional, Jara, Z. P., additional, Barrinha, F. F., additional, Freire, A. O., additional, Casarini, D. E., additional, Teixeira, V. d. P. C., additional, Kose, E., additional, Can, E., additional, Alparslan, C., additional, Dogan, A., additional, Bal, A., additional, Demir, B. K., additional, Anil, M., additional, Anil, A. B., additional, Yavascan, O., additional, Aksu, N., additional, Prusek, J., additional, Szypula, M., additional, Grun, O., additional, Jeken, J., additional, Cremers, B., additional, Steimle, C., additional, Kersting, S., additional, Fliser, D., additional, Heine, G., additional, Pillar, R., additional, Lopes, M. G. G., additional, Cuppari, L., additional, Carvalho, A. B., additional, Canziani, M. E. F., additional, Lipkowska, K., additional, Blumczynski, A., additional, Soltysiak, J., additional, Silska, M., additional, Poprawska, A., additional, Musielak, A., additional, Zaniew, M., additional, Zachwieja, J., additional, Labrador, P. J., additional, and Gonzalez Castillo, P. M., additional

Published
2011
Full Text
View/download PDF

38. Low Molecular Weight Heparin Reduces Proteinuria and Modulates Glomerular TNF-α Production in the Early Phase of Adriamycin Nephropathy.

Author

Benchetrit, S., Golan, E., Podjarny, E., Green, J., Rashid, G., Bernheim, J., and Hershkovitz, R.

Abstract

Background/Aim: Heparin has been shown to be renoprotective in a number of experimental nephropathies. The inflammatory component in the early phase of Adriamycin (ADR) induced nephropathy has been established. A microdose of low molecular weight heparin (Fragmin; F) has been noted to exert immunomodulatory effects independent of its anticoagulant activity. We assessed the effects of microdoses of F on daily proteinuria and glomerular production of tumor necrosis factor alpha (TNF-α) and prostaglandins 8 and 15 days after induction of ADR nephropathy. Methods: Following intravenous injection of ADR (7 mg/kg) to Wistar rats weighing 200 ± 20 g, F 20 μg/day/rat s.c. was administered for 8 and 15 days (groups F8 and F15). The respective control groups (C8 and C15) received normal saline subcutaneously. Proteinuria, serum albumin, and creatinine clearance were evaluated on days 8 and 15. The production of TNF-α and prostaglandins from glomerular supernatants was measured by radioimmunoassay on days 8 and 15. Results: F significantly reduced proteinuria (mg/day) on day 8: 13.6 ± 1.2 in F8 versus 40.3 ± 2.7 in C8 (p = 0.008). The glomerular production of TNF-α (pi/ml) was significantly lower on day 8 in rats treated with F: 356 ± 33 in F8 versus 764 ± 81 in C8 (p = 0.006). A decrease in the prostaglandin E[sub 2] /thromboxane B[sub 2] ratio was noted in the F group between 8 and 15 days (1.1 in F8 vs. 0.9 in F15, p = 0.005) which principally reflects an increase of thromboxane B[sub 2] . The antiproteinuric effect of F shown after 8 days was no longer present after 15 days (354 ± 91 mg/day in F15 vs. 499 ± 69 mg/day in C15, p = 0.33). The same trend was seen for the glomerular production of TNF-α. Light microscopy and immunohistochemistry for interstitial and glomerular macrophages were negative. Conclusion: The lowering effect of microdoses of F on the proteinuria seen during the early phase of ADR nephropathy may be mediated by a decreased production of glomerular TNF-α, supporting the anti-inflammatory action of low molecular weight heparin.Copyright © 2001 S. Karger AG, Basel [ABSTRACT FROM AUTHOR]

Published
2001
Full Text
View/download PDF

40. Prevalence of Cholelithiasis in Non-Diabetic Haemodialysis and Continuous Ambulatory Peritoneal Dialysis Patients.

Author

Korzets, Z., Golan, E., Ben-Chitrit, s., Schneider, N., Chagnac, A., Carel, R., and Bernheim, J.

Abstract

Haemodialyzed (HD) patients have been found to have an increased bile cholesterol level and an increased saturation index in bile. These changes were markedly enhanced in the presence of a low-protein diet. To evaluate whether such changes influence the prevalence of cholelithiasis in patients with end-stage renal failure, real-time sonography was performed to detect the presence of gallstones (GS) in 54 HD (28 males, 26 females, mean age 52.4 ± 15.4 years) and 39 continuous ambulatory peritoneal dialysis (CAPD; 22 males, 17 females, mean age 59.1 ± 14.9 years) patients. No patient had diabetes. The patients’ charts were reviewed for the following data: age, sex, primary renal disease, obesity (20% above ideal weight), history suggestive of gallbladder disease or previous cholecystectomy, duration of dialysis, and serum cholesterol levels. Overall, cholelithiasis was documented in 12 of 93 (12.9%) patients, 7 HD and 5 CAPD. When comparing the factors outlined above, no significant difference was found between HD and CAPD patient groups, either with or without cholelithiasis. Gallbladder disease was asymptomatic in all except 1 patient who required cholecystectomy. Using a healthy control group consisting of local age- and sex-matched inhabitants, GS were found in 8 of 134 (6%) of them (p > 0.05). We conclude that the prevalence rate of GS in our dialysis population (HD and CAPD) is similar to that of a local general population following a western-style diet, irrespective of dialysis mode. [ABSTRACT FROM AUTHOR]

Published
1998
Full Text
View/download PDF

41. Does diurnal variation in blood pressure exist in CAPD patients?

Author

Korzets, Z., Erdberg, A., Golan, E., and Bernheim, J.

Abstract

The existence of diurnal variation in CAPD remains controversial. We therefore attempted to delineate the blood-pressure (BP) pattern in CAPD patients by ambulatory blood-pressure monitoring (ABPM). Initially ABPM was performed in 31 patients (21 M, 10 F), mean age 65.4 years (26–87) using the Spacelabs model 90207. The maximal normal BP preset on the recorder was 140/90 mmHg. Daytime and night-time readings, recorded every 30 min, were defined as those from 0600 to 2100 and 2100 to 0600 hours respectively. Mean duration of dialysis was 15.2 months (3–76). There were 14 hypertensive patients, defined as a basal BP > 140/90 mmHg, or those on antihypertens-ive medications. Taking the group as a whole a significant difference between day and night-time readings was found as regards minimal systolic BP (118 versus 107.6 mmHg), maximal systolic BP (181.6 versus 171.2 mmHg), mean diastolic BP (83.9 versus 79.6 mmHg), and maximal diastolic BP (121.7 versus 104.5 mmHg), <0.05. Diurnal variation, defined in the initial study as a 10% decrease of MAP occurring during any consecutive 4-h period, was present in 21 patients. In three the diurnal variation manifested as a paradoxical reduction of BP during the day. The only significant difference between those with diurnal variation and those without was the duration of dialysis, being 19.2 ±19.9 versus 13.3 ±17.3 months respectively, (<0.05). In a second study 18 hypertensive CAPD patients were subjected to ABPM. Nine of them had participated in the first study. These patients were specifically asked to detail their periods of sleep and arousal. Diurnal variation was here defined as a 10% decrease of MAP occurring 2 h after the onset of sleep. Diurnal variation was found to exist in 10 patients (55%). Comparing the day to night-time readings in this group, no significant differences were found in mean systolic and MAP. When, however, the arousal versus sleep period readings were compared, a significant difference was observed in mean diastolic BP (83±14 versus 77±17mmHg, <0.01), and in the MAP (104 ± 18 versus 98±20.5 mmHg, <0.01). The mean systolic BP just failed to reach statistical significance (141±26 versus 137±30 mmHg) due probably to the small sample size. We conclude that diurnal variation exists in the majority of CAPD patients. Our findings support the concept that the set point model of diurnal variation, in which the major determinant is activity or arousal is the operative one in these patients. Due to disordered sleep patterns in patients on CAPD, diurnal variation might thus be better elicited when taking into account a decrease of MAP occurring during any consecutive 4-h period. [ABSTRACT FROM PUBLISHER]

Published
1994

46. Project PAVE (Personality And Vision Experimentation): Role of personal and interpersonal resilience in the perception of emotional facial expression.

Author

Michal eTanzer, Golan eShahar, and Galia eAvidan

Subjects
angry expression, happy expression, general self-efficacy, perceived social support, biased emotion recognition, Neurosciences. Biological psychiatry. Neuropsychiatry, RC321-571
Abstract

The aim of the proposed theoretical model is to illuminate personal and interpersonal resilience by drawing from the field of emotional face perception. We suggest that perception/recognition of emotional facial expressions serves as a central link between subjective, self-related processes and the social context. Emotional face perception constitutes a salient social cue underlying interpersonal communication and behavior. Because problems in communication and interpersonal behavior underlie most, if not all, forms of psychopathology, it follows that perception/recognition of emotional facial expressions impacts psychopathology. The ability to accurately interpret one's facial expression is crucial in subsequently deciding on an appropriate course of action. However, perception in general, and of emotional facial expressions in particular, is highly influenced by individuals’ personality and the self-concept. Herein we briefly outline well-established theories of personal and interpersonal resilience and link them to the neuro-cognitive basis of face perception. We then describe the findings of our ongoing program of research linking two well-established resilience factors, general self-efficacy (GSE) and perceived social support (PSS), with face perception. We conclude by pointing out avenues for future research focusing on possible genetic markers and patterns of brain connectivity associated with the proposed model. Implications of our integrative model to psychotherapy are discussed.

Published
2014
Full Text
View/download PDF

50. Lesión cerebral traumàtica en los pacientes intoxicados.

Author

Golan, J. D., Marcoux, J., and Golan, E.

Abstract

Objetivo Determinar si la intoxicación por alcohol retrasa la inserción del monitor de presión intracraneal (PIC) en pacientes con una lesión cerebral traumática grave (traumatic brain injury, TBI). [ABSTRACT FROM AUTHOR]

Published
2008

Catalog

Books, media, physical & digital resources
See catalog results